Article
Featured Articles
Read our latest stories on the people and scientific innovations making a difference in patients’ lives.
Real People
Working Together to Empower Women
For Women’s History Month, we’re honoring some of the many ways Pfizer is celebrating and advancing women. Recently, our Pfizer Global Supply site in Vizag, India, found a way to give women more opportunities to work early morning and evening shifts through their “Women In Shifts” program. “We wanted to implement this program in the best way – in line with our Values of everyone being seen, heard and cared for,” said Ravi Kiran Teegala, Human Resources Lead in Vizag, India. The “Women...
Solving the Matchmaking Problem in Precision Medicine Cancer Studies
With the rise of precision medicine, scientists are hopeful that more cancer patients can receive treatments tailored to their specific tumor mutations. But with these advances, a matchmaking problem has also emerged: It can be very challenging to recruit enough patients with specific tumor mutations to participate in clinical trials.However, a pioneering clinical trial model is helping more patients with advanced-stage non-small-cell lung cancer participate in studies that match their tumor...
Living & Wellbeing
How to Practice Self-Care
We’re dedicated to sharing the perspectives of people affected by chronic inflammatory conditions like rheumatoid arthritis (RA). That’s why we created Arthritis.com, a place where people living with RA can find inspiration, lifestyle advice, tools and disease information. Following is an article from Arthritis.com contributor Stephanie Aleite, who is living with RA. Pfizer asked Stephanie to share her story and she was compensated for this article. For me, stress and my rheumatoid arthritis...
A Novel Approach to Hemophilia: Stopping the Body’s Natural Clotting Brakes
Our bodies delicately balance clotting and anti-clotting mechanisms, which help to stop bleeding when there’s an injury or dissolve dangerous clots that can form in blood vessels. But for patients with hemophilia, a rare genetic disease that causes deficiencies in clotting factor VIII or IX, this delicate balance is upset. Patients experience excessive bleeding after an injury and can suffer permanent joint damage following repeated bleeding episodes. For decades, the most common treatment...
Seeking to Improve Quality of Life for Children with Achondroplasia
For children with achondroplasia, the most common type of dwarfism, scientists are exploring new ways to restore bone growth and potentially address some of the major health complications with the condition, such as spinal problems, swelling in the brain, frequent ear infections and sleep apnea. Achondroplasia is a rare genetic bone disorder affecting 1 in 15,000 to 40,000 people in the U.S. The average height for men with the condition is about 4 feet, 4 inches and for women it’s 4 feet...
Mending Broken Walls: 5 Insights About Gut Health Helping IBD Patients
Our skin is the most visible barrier that separates our bodies from the outside world. But deep inside the body, we have another critical wall, the gut epithelial barrier, which helps to block pathogens and toxins, while selectively allowing nutrients and water to be absorbed. “The gut is a very exciting and dynamic kind of barrier,” says Marion Kasaian, Head of Epithelial Biology based at Pfizer’s Kendall Square, Cambridge, Massachusetts research site. “It has a larger surface area than skin...
Meet the New Digital Assistants Transforming Patient Medical Information
Pfizer’s trio of recently launched digital assistants, Medibot in the US, Fabi in Brazil and Maibo in Japan, make it easier for patients and healthcare providers to access medical information. Meet Fabi, a digital assistant with an easy smile and brown curly hair who can make small talk in Portuguese and answer hundreds of questions related to Pfizer’s medicines in Brazil. While chatbots have been around for consumer and retail use for more than two decades, Pfizer is leading the...
Strategies for Managing Inflammatory Bowel Disease (IBD) Symptoms
When biologics to treat inflammatory bowel disease (IBD) were first released over two decades ago, they greatly improved quality of life for many patients. But these first-generation therapies have their shortcomings. Fewer than half of patients treated with these inflammation-blocking drugs will be in remission after one year of treatment. These treatments can also suppress the immune system, making patients vulnerable to infection.But now, thanks to advancements in our understanding of the...
Real People
Eric Hudson: A Lens on Life
I’m a husband and father. A busy regional business director at Pfizer. An endurance athlete. And very grateful to be here. A few years ago, I was training for an Ironman when my left calf became swollen and tight after a long run. I went to an orthopedic surgeon, who did an ultrasound that showed a deep vein thrombosis in my left thigh. After I was admitted to the hospital, an ultrasound showed a pulmonary embolus in one lung. My life changed in that moment. Now I am managing my condition and...
Real People
Dear Scientist: NASH - Meet Ann-Marie
As a bridge between patients and scientists, our own Ann-Marie Richard connects with patients like Jenni Tucker – who was diagnosed with nonalcoholic steatohepatitis at age 19 – to learn about their experiences with NASH, insights that can help guide research toward patients’ needs.
Science & Innovation
Behind the Breakthroughs: The Scientists Behind Pfizer’s Cancer Research
Have you ever wondered what makes a cancer researcher tick, or how the pursuit of life-changing treatments became their life’s work? How about what keeps them up at night, and what goes through their mind when an experiment fails? And what about the things that inspire and motivate them every day in the lab? Click on the videos below to find out, and to get to know the talented scientists at Pfizer who are working to deliver the next wave of cancer breakthroughs. Meet Our Scientists
The Rise of RNA: The Cellular Workhorse Behind a New Class of Next-Gen Therapies
In a new Get Science series, we’re exploring how recent insights into RNA’s role in a variety of biological processes are helping scientists develop promising scientific breathroughs that may lead to new medicines for diseases, such as cancer and autoimmune conditions. A workhorse in the factory Among RNA’s most important roles is the transcription and delivery of genetic instructions from the nucleus to the cytoplasm where proteins are made. RNA also has catalytic, structural and regulatory...
Media Resources & Contact Information
Anyone may view our press releases, press statements, and press kits. However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer Media Contacts may only respond to calls and emails from professional journalists.











